Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021

the CDC Prevention Epicenters Program

doi:10.1017/ash.2022.299

Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021

the CDC Prevention Epicenters Program

Research output: Contribution to journal › Article › peer-review

Abstract

Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2), those with breakthrough infection after vaccination were more likely to have had a non–work-related SARS-CoV-2 exposure compared to unvaccinated HCP.

Original language	English
Article number	e169
Journal	Antimicrobial Stewardship and Healthcare Epidemiology
Volume	2
Issue number	1
DOIs	https://doi.org/10.1017/ash.2022.299
State	Published - Oct 13 2022

Access to Document

10.1017/ash.2022.299

Cite this

@article{1d5233da8caf4ab28c82edfe475de4f5,

title = "Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021",

abstract = "Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3\% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2), those with breakthrough infection after vaccination were more likely to have had a non–work-related SARS-CoV-2 exposure compared to unvaccinated HCP.",

author = "\{the CDC Prevention Epicenters Program\} and Nickel, \{Katelin B.\} and Fraser, \{Victoria J.\} and Babcock, \{Hilary M.\} and Jennie Kwon",

note = "Funding Information: This study was supported by the Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program (grant nos. U54CK00482 to V.J.F. and BAA 75D301-20-R-68024 contract no. 75D30121C10185 to J.H.K.). J.H.K. is also supported by the NIH National Institute of Allergy and Infectious Diseases (grant no. 1K23AI137321-01A1). Publisher Copyright: {\textcopyright} The Author(s), 2022.",

year = "2022",

month = oct,

day = "13",

doi = "10.1017/ash.2022.299",

language = "English",

volume = "2",

journal = "Antimicrobial Stewardship and Healthcare Epidemiology",

issn = "2732-494X",

number = "1",

}

TY - JOUR

T1 - Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021

AU - the CDC Prevention Epicenters Program

AU - Nickel, Katelin B.

AU - Fraser, Victoria J.

AU - Babcock, Hilary M.

AU - Kwon, Jennie

N1 - Funding Information: This study was supported by the Centers for Disease Control and Prevention (CDC) Prevention Epicenters Program (grant nos. U54CK00482 to V.J.F. and BAA 75D301-20-R-68024 contract no. 75D30121C10185 to J.H.K.). J.H.K. is also supported by the NIH National Institute of Allergy and Infectious Diseases (grant no. 1K23AI137321-01A1). Publisher Copyright: © The Author(s), 2022.

PY - 2022/10/13

Y1 - 2022/10/13

N2 - Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2), those with breakthrough infection after vaccination were more likely to have had a non–work-related SARS-CoV-2 exposure compared to unvaccinated HCP.

AB - Coronavirus disease 2019 (COVID-19) vaccine effectiveness in the early months of vaccine availability was high among healthcare personnel (HCP) at 88.3% for 2-doses. Among those testing positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2), those with breakthrough infection after vaccination were more likely to have had a non–work-related SARS-CoV-2 exposure compared to unvaccinated HCP.

UR - https://www.scopus.com/pages/publications/85141124309

U2 - 10.1017/ash.2022.299

DO - 10.1017/ash.2022.299

M3 - Article

C2 - 36483397

AN - SCOPUS:85141124309

SN - 2732-494X

VL - 2

JO - Antimicrobial Stewardship and Healthcare Epidemiology

JF - Antimicrobial Stewardship and Healthcare Epidemiology

IS - 1

M1 - e169

ER -

Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections among healthcare personnel, December 2020–April 2021

Abstract

Access to Document

Other files and links

Fingerprint

Cite this